Skip to content

A Comparison between two different combinations for carrying out procedure of emesis in psoriasis patients.

A Randomized parallel group active controlled trial to evaluate comparative efficacy of kutajadi vamaka yoga versus madanadi vamaka yoga in the management of Ekakushtha (Psoriasis)

Status
Recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/02/049747
Enrollment
78
Registered
2023-02-15
Start date
Unknown
Completion date
Unknown
Last updated
2023-03-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L409- Psoriasis, unspecified

Interventions

None listed

Sponsors

NIl
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.The patients who have given written informed consent. 2.Subjects fulfilling the eligibility criteria of Vamana (vamanarha). 3.Subjects with classical Lakshanas of Ekakushtha (Psoriasis) and clinical features of Psoriasis. 4.Subjects in moderate and severe category of psoriasis on basis of PASI scale (PASI score 5to 10, 10 and above). 5.Following types of Psoriasis were included: Plaque, Guttate, Palmoplantar 6.Subjects who have stopped medications for psoriasis for the last 90 days.

Exclusion criteria

Exclusion criteria: 1.Ekakushtha (Psoriasis) with extra cutaneous manifestations. 2.Subjects with uncontrolled metabolic disorders. 3.Patients with other systemic disorders which might interfere with the psoriasis treatment.

Design outcomes

Primary

MeasureTime frame
TO find the better combination for vamana for Shifting psoriasis patients from moderate to severe group (PASI score 5 or more) to mild to no psoriasis (0 to 5 score)Timepoint: 15 days

Secondary

MeasureTime frame
1.To assess the efficacy of madanadi vamaka yoga on severity of psoriasis by its ability of shifting the patients from moderate to severe group to mild to nothing group. 2. To assess the efficacy of Kutajadi vamaka yoga on severity of psoriasis by its ability of shifting the patients from moderate to severe group to mild to nothing group.Timepoint: on the next day of vamana, 3 days after vamana, 7 days after vamana

Countries

India

Contacts

Public ContactDr Shweta Parwe

Mahatma Gandhi Ayurved College, Hospital and Research Center, Salod, Wardha

drshwetaparve@gmail.com9511659185

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026